John D Sparkes
Overview
Explore the profile of John D Sparkes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Segev A, Nili N, Qiang B, Osherov A, Giordano F, Jaffe R, et al.
J Mol Cell Cardiol
. 2010 Nov;
50(3):417-25.
PMID: 21081134
We evaluated the role of p15(Ink4), a member of the INK4 family of CDK inhibitors on vascular smooth muscle cells (VSMCs) proliferation, cell cycle progression and intimal hyperplasia after stenting....
12.
Munce N, Strauss B, Qi X, Weisbrod M, Anderson K, Leung G, et al.
JACC Cardiovasc Imaging
. 2010 Aug;
3(8):797-805.
PMID: 20705258
Objectives: The purpose of this study was to characterize the 3-dimensional structure of intravascular and extravascular microvessels during chronic total occlusion (CTO) maturation in a rabbit model. Background: Intravascular microchannels...
13.
Charron T, Jaffe R, Segev A, Bang K, Qiang B, Sparkes J, et al.
Thromb Res
. 2010 Jun;
126(1):50-5.
PMID: 20541052
Introduction: Myocardial hypoperfusion following percutaneous coronary intervention, termed "no-reflow", may be initiated by distal coronary embolization. This study examined the effects of distal embolization on the extent and timing of...
14.
Fefer P, Daoulah A, Strauss B, Chisholm R, Sparkes J, Segev A
Catheter Cardiovasc Interv
. 2010 May;
76(7):960-6.
PMID: 20506211
Objectives: To assess whether visible angiographic complication is related to outcome in patients with elevated creatine phosphokinase (CK-MB) following percutaneous coronary intervention (PCI). Background: Elevated biomarkers following PCI are associated...
15.
Jaffe R, Leung G, Munce N, Thind A, Leong-Poi H, Anderson K, et al.
J Am Coll Cardiol
. 2009 Mar;
53(13):1148-58.
PMID: 19324261
Objectives: We sought to perform the first systematic study of the natural history of chronic total arterial occlusions (CTOs) in an experimental model. Background: Angioplasty of CTOs has low success...
16.
Wong A, Nili N, Jackson Z, Qiang B, Leong-Poi H, Jaffe R, et al.
Atherosclerosis
. 2007 Aug;
196(2):580-9.
PMID: 17692852
Objective: To date, intimal hyperplasia has been regarded as the principle mechanism responsible for subsequent vein graft disease. Lumen remodeling has not been previously considered as an additional mechanism. The...
17.
Kutryk M, Kuliszewski M, Jaffe R, Tio F, Janicki C, Sweet W, et al.
Cardiovasc Revasc Med
. 2007 Feb;
8(1):28-37.
PMID: 17293266
Purpose: The objective of this study was to determine the effects of different doses of gamma-emitting radioactive stents on intimal hyperplasia in a porcine coronary stent model at 28 days....
18.
Segev A, Ellis M, Segev F, Friedman Z, Reshef T, Sparkes J, et al.
Int J Cardiol
. 2005 Feb;
98(3):421-4.
PMID: 15708174
Background: Thrombophilia refers to series of acquired and inherited conditions that confer a tendency to thrombus formation. The exact relationship between thrombophilia and MI is not well established. Objectives: To...
19.
Segev A, Hegele R, Lau H, Sparkes J, Teitel J, Chisholm R, et al.
Thromb Res
. 2004 Aug;
114(2):137-41.
PMID: 15306156
Background: The fibrinolytic system is closely related to several processes that are involved in restenosis. We have previously shown that high pre-procedural plasma levels of thrombin-activatable fibrinolysis inhibitor (TAFI) antigen...
20.
Segev A, Kassam S, Buller C, Lau H, Sparkes J, Connelly P, et al.
Eur Heart J
. 2004 Jun;
25(12):1029-35.
PMID: 15191773
Aims: Inflammatory markers may serve as an important prognostic predictor in patients with coronary heart diseases. In patients undergoing coronary interventions, it has been shown that baseline C-reactive protein (CRP)...